Euro Diagnostica, a leader in diagnostic solutions
Euro Diagnostica’s goal is to constantly develop solutions to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune and related diseases. In July 2014 Euro Diagnostica entered into a merger agreement with Biomonitor, a leading company in theranostics and personalized medicine. Today Euro Diagnostica is based on four segments; a portfolio of ELISA and RIA kits, drug monitoring, Wieslab Lab Services and custom manufacturing/OEM services.
Top quality ELISA and RIA kits: Key products are our ANCA, anti-CCP 2, chromogranin and complement assays, which are developed in collaboration with our world class scientists and key opinion leaders.
Drug monitoring: Biomonitor’s patented cell-based assay platform iLite™, based on reporter gene technology, can both monitor functional drug activity and detect neutralizing antibodies. This provides a unique and extremely versatile tool for optimizing patient treatment. Moreover, the technology can be used to customize assay development during different stages of development of biologicals/biosimilars.
Wieslab Lab Services: Wieslab is an integral part of Euro Diagnostica and offers testing services for most autoimmune diseases. Recently Wieslab has introduced a panel of neurology markers, PANDAS/PANS-testing and tests for TNF blockers to the test menu.
Custom Manufacturing and OEM services: Euro Diagnostica, with 20 years' experience of OEM and Custom Manufacturing, through a highly skilled and dedicated manufacturing team, offers:
• ELISA & RIA kit production and development
• Production optimization support
• Antigens and antibodies
• Automation validation